Skip to search formSkip to main contentSkip to account menu

interferon beta-1b 0.3 MG Injection [Betaseron]

Known as: INTERFERON BETA-1B 0.3MG/VIL (BETASERON), INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON), Betaseron 0.3 MG Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
In der wechselvollen und sehr dynamischen Entwicklung der Therapien der Multiplen Sklerose (MS) stellt Interferon beta-1b… 
2012
2012
Interferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high-frequency… 
Review
2009
Review
2009
ABSTRACT Background: Interferon beta (IFNβ) is a disease-modifying therapy for multiple sclerosis (MS). Although clinical… 
2009
2009
Background: Interferon beta (IFNβ) administered subcutaneously is immunogenic in some patients with multiple sclerosis (MS) and… 
2008
2008
  • P. O'Connor
  • 2008
  • Corpus ID: 23698338
Health Canada approved medications for the treatment of multiple sclerosis (MS): Avonex® (Interferon Beta 1a), Betaseron… 
1998
1998
Recently approved therapies for treatment of relapsing-remitting multiple sclerosis (MS) include interferon β1b (IFNβ1b… 
1998
1998
“Late Breaking News” (formerly “Works in Progress”) is a feature of the Scientific Program of the American Academy of Neurology… 
1993
1993
The approval of Betaseron® has drawn attention to the potential of immune modulation as a means of treating multiple sclerosis…